A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier
Read moreHome »
Behavioral
Behavioral, psych condition care shifted to telemedicine during COVID-19
(HealthDay)—Office-based visits for behavioral and psychiatric conditions decreased in association with the COVID-19 pandemic, although increases in telemedicine visits offset
Read more